Skip to main content
Livermore
Livermore
ZHEN

Vigil Neuroscience, Inc.

VIGLDelisted Aug 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827087

Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.

Holders of 5% or more of VIGL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vigil Neuroscience, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of VIGL
HolderLatest formStakeChangeFirst filedLatest filingFiling
Glazer Capital, LLC13G/A6.45%3.01M shares+1.06 ppfrom 5.39%Jun 4, 20252 filingsAug 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

11 Schedule 13D and 13G filings on Vigil Neuroscience, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on VIGL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20252:32 PM ETBeryl Capital Management LLCand 3 others13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Sep 30, 2025SEC
Aug 14, 20254:07 PM ETBiotechnology Value Fund L Pand 9 others13G/A0.00%0 shares−9.99 ppfrom 9.99%Below 5%Jun 30, 2025SEC
Aug 14, 20251:45 PM ETGlazer Capital, LLCand 1 other13G/A6.45%3.01M shares+1.06 ppfrom 5.39%Jun 30, 2025SEC
Aug 7, 20255:11 PM ETAtlas Venture Fund XII, L.P.and 5 others13D/A0.00%0 shares–Below 5%Aug 5, 2025SEC
Jun 12, 20255:33 PM ETVida Ventures GP III, L.L.C.and 2 others13D/A3.50%1.63M shares−2.60 ppfrom 6.10%Below 5%Jun 10, 2025SEC
Jun 9, 20255:48 PM ETVida Ventures GP III, L.L.C.and 2 others13D/A6.10%2.84M shares–Jun 5, 2025SEC
Jun 4, 20255:24 PM ETGlazer Capital, LLCand 1 other13G5.39%2.51M sharesNewMay 28, 2025SEC
May 30, 20255:04 PM ETBeryl Capital Management LLCand 3 others13G9.90%4.61M sharesNewMay 22, 2025SEC
May 27, 20256:26 PM ETNorthpond Ventures, LPand 4 others13D/A0.00%0 shares–Below 5%May 22, 2025SEC
May 15, 20254:42 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%4.73M shares–Mar 31, 2025SEC
Feb 12, 20254:30 PM ETInvus Global Management, LLCand 7 others13G/A4.90%1.99M shares–Below 5%Dec 31, 2024SEC
Mar 29, 2024Artal International S.C.A.13G/AOld format–––SEC
Feb 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Feb 14, 2024Citadel Advisors LLC13G/AOld format–––SEC
Feb 12, 2024Flynn James E13G/AOld format–––SEC
Feb 9, 2024Artal International S.C.A.13G/AOld format–––SEC
Feb 14, 2023Hatteras Venture Partners VI, LP13GOld format–New–SEC
Feb 14, 2023Citadel Advisors LLC13G/AOld format–––SEC
Feb 13, 2023Artal International S.C.A.13G/AOld format–––SEC
Feb 10, 2023Flynn James E13G/AOld format–––SEC
Feb 10, 2023Vida Ventures GP III, L.L.C.13DOld format–New–SEC
Dec 16, 2022Northpond Ventures, LP13D/AOld format–––SEC
Aug 26, 2022Biotechnology Value Fund L P13GOld format–New–SEC
Aug 23, 2022Artal International S.C.A.13GOld format–New–SEC
Aug 22, 2022Deep Track Capital, LP13GOld format–New–SEC
Aug 16, 2022Flynn James E13GOld format–New–SEC
Jan 21, 2022Atlas Venture Fund XII, L.P.13DOld format–New–SEC
Jan 21, 2022Citadel Advisors LLC13GOld format–New–SEC
Jan 19, 2022Northpond Ventures, LP13DOld format–New–SEC
Jan 11, 20229:33 PM ETAmgen Inc13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Vigil Neuroscience, Inc. shares.

No Form 144 notices for Vigil Neuroscience, Inc. are on file.